Kwarlay.com

Navigating the News Maze with Clarity

    • Medicine

    AbbVie, OSE Immunotherapeutics Strike Deal to Develop Monoclonal Antibody for Chronic Inflammation

    admin Posted on

    OSE-230 was developed to activate a unique mechanism for resolving chronic inflammation, focusing on modulation of macrophages and neutrophils.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Slot
    TOGEL ONLINE